Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL

Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL

WUSTL

1 month
23 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Katherine Clifton, MD @katherineclift4 of @WUSTL discusses actionable fusions as an anti-EGFR resistance mechanism.

__________

Read here: https://ascopubs.org/doi/10.1200/PO.19.00141

Up Next Autoplay
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Category: Colorectal Cancer
3 Views
WUSTL 1 month
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
11 Views
Cancer-News 1 month
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
70 Views
Cancer-News 1 month
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
29 Views
Cancer-News 2 months
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
10 Views
Cleveland Clinic 2 months
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
4 Views
Cleveland Clinic 2 months
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
12 Views
Cleveland Clinic 2 months
IDEA: Factors to consider
IDEA: Factors to consider
Category: Colorectal Cancer
3 Views
moasc 3 months
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
3 Views
moasc 3 months